Partnering opportunities

A DC subset with superior antigen-presenting capability, engineered with a proprietary CAR design for immunotherapy.

Platform technology to make CAR-T cell therapy less toxic while improving efficacy​.

A new therapy for global prevention of hemolytic disease of the newborn

Method to induce stem-like memory T cells for long-lived response in vaccine design

Oral therapeutic targeting diverse coronavirus PLpros; potential to minimise progression to severe disease and post-acute sequelae of COVID-19 (PASC / Long COVID).

Oral therapeutic targeting coronavirus Mpro; potential to minimise progression to severe disease and post-acute sequelae of COVID-19 (PASC / Long COVID).

A high-throughput laboratory-based diagnostic for detecting hidden or cryptic liver stage Plasmodium vivax infections.

A genetically-defined, attenuated parasite strain to protect sheep and other mammals from Toxoplasma infection

Using an epigenetic approach to turn on genes, the absence of which causes Prader Willi Syndrome, a devistating neurodevelopment disorder

Disrupting cell death pathways to prevent a number of diseases including Parkinson’s.

Platform developing TPDs against cancer, including novel E3 ligase warheads.

Develop specific and potent inhibitors of IL-11 signaling as novel therapies for cancer and fibro-inflammatory disease.

A comprehensive software as a service system for managing research animals and ethics.